Daniela Rubino

956 total citations
28 papers, 316 citations indexed

About

Daniela Rubino is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Daniela Rubino has authored 28 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Daniela Rubino's work include HER2/EGFR in Cancer Research (8 papers), Breast Cancer Treatment Studies (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Daniela Rubino is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Breast Cancer Treatment Studies (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Daniela Rubino collaborates with scholars based in Italy, Switzerland and Australia. Daniela Rubino's co-authors include Dirk Fischer, Patricia Hafner, Leo H. Bonati, Nuri Gueven, M Gloor, Oliver Bieri, Arne Fischmann, Thomas Zumbrunn, Claudio Zamagni and Erich Rutz and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Daniela Rubino

26 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Rubino Italy 10 153 62 62 37 36 28 316
Maria Mancini United States 8 126 0.8× 45 0.7× 36 0.6× 23 0.6× 43 1.2× 18 272
Jianwei Xu China 12 115 0.8× 23 0.4× 37 0.6× 10 0.3× 31 0.9× 27 292
Zheng Yan China 11 114 0.7× 40 0.6× 62 1.0× 66 1.8× 26 0.7× 27 390
Tommaso Rizzuti Italy 10 139 0.9× 31 0.5× 62 1.0× 16 0.4× 70 1.9× 29 335
Mengyu Zhu China 10 84 0.5× 39 0.6× 19 0.3× 50 1.4× 20 0.6× 23 289
Jessica Tarn United Kingdom 11 77 0.5× 52 0.8× 209 3.4× 20 0.5× 80 2.2× 28 421
Niels A. Hammer Denmark 7 281 1.8× 21 0.3× 53 0.9× 14 0.4× 90 2.5× 7 487
R. Schwendimann United States 10 73 0.5× 36 0.6× 30 0.5× 10 0.3× 20 0.6× 27 323
Tetsuya Oishi Japan 10 105 0.7× 16 0.3× 11 0.2× 65 1.8× 41 1.1× 33 420

Countries citing papers authored by Daniela Rubino

Since Specialization
Citations

This map shows the geographic impact of Daniela Rubino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Rubino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Rubino more than expected).

Fields of papers citing papers by Daniela Rubino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Rubino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Rubino. The network helps show where Daniela Rubino may publish in the future.

Co-authorship network of co-authors of Daniela Rubino

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Rubino. A scholar is included among the top collaborators of Daniela Rubino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Rubino. Daniela Rubino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perrone, Anna Myriam, et al.. (2025). Continuing chemotherapy beyond 6 cycles increases the chances of complete cytoreduction surgery in patients with advanced ovarian cancer. European Journal of Surgical Oncology. 51(9). 110288–110288.
2.
Starace, Michela, Francesca Bruni, Cosimo Misciali, et al.. (2024). Management of cutaneous adverse events caused by antineoplastic therapies: a single-center experience. Supportive Care in Cancer. 32(3). 200–200. 1 indexed citations
3.
Perrone, Anna Myriam, Camelia Alexandra Coadǎ, Gloria Ravegnini, et al.. (2023). Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma. International Journal of Gynecological Cancer. 33(8). 1270–1278. 11 indexed citations
4.
Gross, Elena C., Simone Schmidt, Patricia Hafner, et al.. (2023). Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial. Frontiers in Pharmacology. 14. 1172483–1172483. 1 indexed citations
5.
Barbero, Giovanna, Roberta Zuntini, Pamela Magini, et al.. (2023). Characterization of BRCA Deficiency in Ovarian Cancer. Cancers. 15(5). 1530–1530. 1 indexed citations
6.
Starace, Michela, Emi Dika, Alessandro Pileri, et al.. (2022). Management of malignant cutaneous wounds in oncologic patients. Supportive Care in Cancer. 30(9). 7615–7623. 14 indexed citations
7.
Schmidt, Simone, Daniela Rubino, Tanja Haas, et al.. (2021). Treatment with L‐Citrulline in patients with post‐polio syndrome: A single center, randomized, double blind, placebo‐controlled trial. Neuromuscular Disorders. 31(11). 1136–1143. 1 indexed citations
8.
Gross, Elena C., Simone Schmidt, Patricia Hafner, et al.. (2021). Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial. Cephalalgia. 42(4-5). 302–311. 10 indexed citations
9.
Orlando, Laura, Antonio Febbraro, Claudio Zamagni, et al.. (2019). Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience. Tumori Journal. 106(4). 301–305. 2 indexed citations
10.
Ceccarelli, Claudio, Antonio De Leo, Pasquale Chieco, et al.. (2019). A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed. PLoS ONE. 14(6). e0217937–e0217937. 8 indexed citations
11.
12.
13.
Minichillo, Santino, Ilaria Gallelli, Daniela Rubino, et al.. (2017). Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report. BMC Cancer. 17(1). 722–722. 5 indexed citations
14.
Conté, Pierfranco, Giancarlo Bisagni, Antonio Frassoldati, et al.. (2017). 9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER.. Journal of Clinical Oncology. 35(15_suppl). 501–501. 22 indexed citations
15.
Barbieri, Elena, et al.. (2017). Eribulin long-term response and rechallenge: report of two clinical cases. Future Oncology. 13(sup11). 35–43. 3 indexed citations
16.
Orlando, Laura, Giovanna Giordano, Claudio Zamagni, et al.. (2016). Safety and efficacy of eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients. An Italian multicenter experience. Annals of Oncology. 27. vi76–vi76.
17.
Fischer, Dirk, Patricia Hafner, Daniela Rubino, et al.. (2016). The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study. Neuromuscular Disorders. 26(7). 414–422. 34 indexed citations
18.
Hafner, Patricia, Leo H. Bonati, Beat Erne, et al.. (2016). Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study. PLoS ONE. 11(1). e0147634–e0147634. 65 indexed citations
19.
Hafner, Patricia, Leo H. Bonati, Daniela Rubino, et al.. (2016). Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial. Trials. 17(1). 389–389. 31 indexed citations
20.
Diemberger, Igor, Giulia Massaro, Daniela Rubino, et al.. (2015). Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs. European Journal of Clinical Pharmacology. 71(8). 1001–1009. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Mancini Breakdown of academic impact, for papers by Jianwei Xu Breakdown of academic impact, for papers by Zheng Yan Breakdown of academic impact, for papers by Tommaso Rizzuti Breakdown of academic impact, for papers by Mengyu Zhu Breakdown of academic impact, for papers by Jessica Tarn Breakdown of academic impact, for papers by Niels A. Hammer Breakdown of academic impact, for papers by R. Schwendimann Breakdown of academic impact, for papers by Tetsuya Oishi
Rankless by CCL
2026